Peter Lanbeck

625 total citations
18 papers, 433 citations indexed

About

Peter Lanbeck is a scholar working on Pharmacology, Epidemiology and Emergency Medical Services. According to data from OpenAlex, Peter Lanbeck has authored 18 papers receiving a total of 433 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmacology, 5 papers in Epidemiology and 5 papers in Emergency Medical Services. Recurrent topics in Peter Lanbeck's work include Central Venous Catheters and Hemodialysis (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Sepsis Diagnosis and Treatment (4 papers). Peter Lanbeck is often cited by papers focused on Central Venous Catheters and Hemodialysis (5 papers), Antibiotics Pharmacokinetics and Efficacy (5 papers) and Sepsis Diagnosis and Treatment (4 papers). Peter Lanbeck collaborates with scholars based in Sweden, Austria and United Kingdom. Peter Lanbeck's co-authors include Otto Paulsen, Inga Odenholt, Mats Walder, Marlene Wullt, Lisa Mellhammar, Bértil Christensson, Adam Linder, Patrik Medstrand, Anders Widell and Per Åkesson and has published in prestigious journals such as Clinical Infectious Diseases, Critical Care Medicine and International Journal of Pharmaceutics.

In The Last Decade

Peter Lanbeck

17 papers receiving 415 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Lanbeck Sweden 13 118 109 108 95 45 18 433
Muriel S. Shannon United Kingdom 9 131 1.1× 164 1.5× 101 0.9× 93 1.0× 64 1.4× 17 661
Miguel Sánchez Spain 8 50 0.4× 73 0.7× 67 0.6× 153 1.6× 54 1.2× 16 421
Per Engervall Sweden 15 56 0.5× 143 1.3× 46 0.4× 161 1.7× 54 1.2× 31 581
Pierre‐Marie Roger France 13 43 0.4× 50 0.5× 108 1.0× 164 1.7× 67 1.5× 56 492
Hana Hakim United States 15 71 0.6× 75 0.7× 157 1.5× 326 3.4× 38 0.8× 44 739
F.N.J. Frakking Netherlands 13 120 1.0× 61 0.6× 68 0.6× 119 1.3× 37 0.8× 25 534
Carmi Bartal Israel 12 72 0.6× 51 0.5× 46 0.4× 93 1.0× 103 2.3× 25 505
Sanjiv M. Baxi United States 14 79 0.7× 45 0.4× 364 3.4× 147 1.5× 51 1.1× 32 640
Richard Flowers United States 10 108 0.9× 163 1.5× 208 1.9× 275 2.9× 51 1.1× 35 612
Basel Al Raiy United States 4 100 0.8× 97 0.9× 376 3.5× 75 0.8× 41 0.9× 4 542

Countries citing papers authored by Peter Lanbeck

Since Specialization
Citations

This map shows the geographic impact of Peter Lanbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Lanbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Lanbeck more than expected).

Fields of papers citing papers by Peter Lanbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Lanbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Lanbeck. The network helps show where Peter Lanbeck may publish in the future.

Co-authorship network of co-authors of Peter Lanbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Lanbeck. A scholar is included among the top collaborators of Peter Lanbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Lanbeck. Peter Lanbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Tham, Johan, et al.. (2020). Improved Outcomes After Regional Implementation of Sepsis Alert: A Novel Triage Model*. Critical Care Medicine. 48(4). 484–490. 13 indexed citations
2.
Alsved, Malin, Carl‐Johan Fraenkel, Mats Bohgard, et al.. (2019). Sources of Airborne Norovirus in Hospital Outbreaks. Clinical Infectious Diseases. 70(10). 2023–2028. 63 indexed citations
3.
Lanbeck, Peter, et al.. (2017). Sepsis Alert – a triage model that reduces time to antibiotics and length of hospital stay. Infectious Diseases. 49(7). 507–513. 19 indexed citations
4.
Walder, Mats, Nathalie Y. Uzcátegui, Inga Odenholt, et al.. (2016). Hydrogen Peroxide Vapor Decontamination in a Patient Room Using Feline Calicivirus and Murine Norovirus as Surrogate Markers for Human Norovirus. Infection Control and Hospital Epidemiology. 37(5). 561–566. 15 indexed citations
5.
Lanbeck, Peter, Gunnel Ragnarson Tennvall, & Fredrik Resman. (2016). A cost analysis of introducing an infectious disease specialist-guided antimicrobial stewardship in an area with relatively low prevalence of antimicrobial resistance. BMC Health Services Research. 16(1). 311–311. 19 indexed citations
6.
Mellhammar, Lisa, et al.. (2016). Sepsis Incidence: A Population-Based Study. Open Forum Infectious Diseases. 3(4). ofw207–ofw207. 54 indexed citations
7.
Engblom, Johan, et al.. (2015). Do surface active parenteral formulations cause inflammation?. International Journal of Pharmaceutics. 484(1-2). 246–251. 3 indexed citations
8.
Lanbeck, Peter, et al.. (2013). Design for the Post-Antibiotic Era: Experiences from a New Building for Infectious Diseases in Malmö, Sweden. HERD Health Environments Research & Design Journal. 6(4). 27–52. 11 indexed citations
9.
Lanbeck, Peter, et al.. (2011). A Head-to-Head Comparison of Hydrogen Peroxide Vapor and Aerosol Room Decontamination Systems. Infection Control and Hospital Epidemiology. 32(9). 831–836. 43 indexed citations
10.
Vikerfors, Tomas, et al.. (2011). [National quality registry can improve care in life-threatening sepsis].. PubMed. 108(6). 279–81. 1 indexed citations
11.
Björkander, Janne, J Nikoskelainen, Heinz Leibl, et al.. (2006). Prospective open‐label study of pharmacokinetics, efficacy and safety of a new 10% liquid intravenous immunoglobulin in patients with hypo‐ or agammaglobulinemia. Vox Sanguinis. 90(4). 286–293. 40 indexed citations
12.
13.
Lanbeck, Peter, Inga Odenholt, & Otto Paulsen. (2004). Perception of Risk Factors for Infusion Phlebitis Among Swedish Nurses. Journal of Infusion Nursing. 27(1). 25–30. 21 indexed citations
14.
Lanbeck, Peter, Inga Odenholt, & Otto Paulsen. (2003). Dicloxacillin: A Higher Risk than Cloxacillin for Infusion Phlebitis. Scandinavian Journal of Infectious Diseases. 35(6-7). 397–400. 15 indexed citations
15.
Lanbeck, Peter, Inga Odenholt, & Otto Paulsen. (2002). Antibiotics Differ in Their Tendency to Cause Infusion Phlebitis: A Prospective Observational Study. Scandinavian Journal of Infectious Diseases. 34(7). 512–519. 62 indexed citations
16.
Lanbeck, Peter & Otto Paulsen. (2001). Short-Term Effects of Four Antibiotics on DNA Synthesis in Endothelial CellsNote. Pharmacology & Toxicology. 88(4). 204–208. 9 indexed citations
17.
Lanbeck, Peter & Otto Paulsen. (2001). Short‐Term Effects of Four Antibiotics on DNA Synthesis in Endothelial CellsNote. Pharmacology & Toxicology. 88(4). 204–208.
18.
Lanbeck, Peter & Otto Paulsen. (1995). Cytotoxic Effects of Four Antibiotics on Endothelial Cells. Pharmacology & Toxicology. 77(6). 365–370. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026